Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-21

Clinical Trial Update: Accuracy of Urinary NGAL in Predicting CardioRenal Syndrome in Acute Heart Failure at Emergency - CYNDERELA-HF Study

View source ↗

Summary

A clinical trial evaluating the accuracy of urinary NGAL for predicting cardiorenal syndrome in patients with acute heart failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pro-Cardiaco Hospital | Conditions: Cardiorenal Syndrome | Status: TERMINATED